Tradestie Institutional Equity Comparison Engine

SBRA vs XRN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SBRA Overall Edge

SBRA Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sabra Healthcare REIT, Inc. (SBRA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SBRA trades at 30.4x Forward P/E with 18.4% operating margin (+31.6% YoY revenue) versus XRN at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, SBRA sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro) against XRN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SBRA
SBRA 30.4x vs XRN N/M Fwd P/E
Growth & Margin Winner SBRA
Op Margin 18.4% vs N/A ยท YoY +31.6% vs N/A
Momentum & Technical Winner SBRA
1Y +8.7% vs -28.2% ยท 52W Pos 52% vs 1%
Options & Structure Winner SBRA
CONSOLIDATION (17th %ile IV) vs UNCLASSIFIED (N/A IV)
SBRA NASDAQ
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.27
-0.37% 1D
Market Cap $5.4B
1M Return +6.26%
1Y Return +8.71%
Forward P/E 30.4x
Unified AI Score
57.4 / 100 HOLD
Tech 49.0 Fund 57.0 Flow 57.0 Mom 64.0
XRN US Equity
XRN
Institutional Equity
$25.79
-2.35% 1D
Market Cap N/A
1M Return -13.02%
1Y Return -28.16%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SBRA +8.71% XRN -28.16% Spread: +27.4 pp (SBRA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SBRA TTM Op. Margin: 18.4% XRN TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SBRA vs XRN. Trailing 12-month operating profitability (SBRA 18.4% vs XRN N/A) and valuation multiples (SBRA 30.4x vs XRN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SBRA (10) vs XRN (0)
Institutional Metric SBRA XRN Criterion Row Winner
Market Capitalization Scale $5.4B N/A Larger Scale SBRA
Trailing P/E Ratio Valuation 75.7x N/M Lower Multiple SBRA
Forward P/E Ratio Valuation 30.4x N/M Lower Multiple SBRA
Revenue Growth (YoY) Growth +31.6% N/A Higher Growth SBRA
Operating Margin (TTM) Profitability 18.4% N/A Higher Margin SBRA
Net Profit Margin Profitability 7.7% N/A Higher Margin SBRA
Return on Equity (ROE) Capital Efficiency 2.5% N/A Higher ROE SBRA
52-Week Range Position Momentum 52% ($18โ€“$23) 1% ($26โ€“$39) Stronger Trend SBRA
Beta / 30D Volatility Risk Regime 0.00ฮฒ ยท 30% Vol 0.50ฮฒ ยท 47% Vol Lower Realized Risk SBRA
Unified Institutional Score Composite Signal 57.4 / 100 (HOLD) 45.3 / 100 (HOLD) Higher Composite SBRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SBRA vs XRN Buy Guide
SBRA CONSOLIDATION
80d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live SBRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XRN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XRN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SBRA nor XRN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.